作者: Terence E Hartnett , Andrea J O’Connor , Katharina Ladewig
DOI: 10.1517/17425247.2015.1021680
关键词:
摘要: Introduction: Many macromolecular therapeutics designed to treat posterior segment eye diseases (PSEDs) are administered through frequent ocular injection, which can further …